Encorafenib with binimetinib for treating BRAF V600E mutation-positive advanced non-small-cell lung cancer

Evaluation committee members

The 4 technology appraisal committees are standing advisory committees of NICE. This topic was considered by committee C.

Committee members are asked to declare any interests in the technologies being evaluated. If it is considered there is a conflict of interest, the member is excluded from participating further in that evaluation.

The minutes of each evaluation committee meeting, which include the names of the members who attended and their declarations of interests, are posted on the NICE website.

Chairs

Professor Stephen O'Brien and Dr Richard Nicholas
Chairs, technology appraisal committee C

NICE project team

Each evaluation is assigned to a team consisting of 1 or more health technology analysts (who act as technical leads for the evaluation), a technical adviser, a project manager and an associate director.

Alice Pritchard
Technical lead

Samuel Slayen
Technical adviser

Louise Jafferally and Leena Issa
Project managers

Ross Dent and Lorna Dunning
Associate directors

ISBN: 978-1-4731-9463-2